BARD CONTIGEN IMPLANT 651005

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00 report with the FDA on 2001-04-16 for BARD CONTIGEN IMPLANT 651005 manufactured by C.r. Bard, Inc..

Event Text Entries

[221279] Patient developed urethra hypersensitivity and painful urination 2 weeks after contigen implant. Skin test remains clear with no signs of a reaction. Doctor had not performed any urine culture or any testing to diagnose patient. On 4/9/01, follow-up with reporter indicated patient was still experiencing burning and itching sensation after having been treated with topical steroids. Several cultures were reportedly performed with no growth detected. Doctor was bringing patient in for a washout procedure intended to remove the contigen.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1018233-2001-00011
MDR Report Key327653
Report Source00
Date Received2001-04-16
Report Date2001-04-12
Date Mfgr Received2001-04-10
Date Added to Maude2001-04-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactVIVIAN STEPHENS, MGR
Manufacturer Street8195 INDUSTRIAL BLVD.
Manufacturer CityCOVINGTON GA 30014
Manufacturer CountryUS
Manufacturer Postal30014
Manufacturer Phone7707846902
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameBARD CONTIGEN IMPLANT
Generic NameINCONTINENCE IMPLANT
Product CodeLMI
Date Received2001-04-16
Model NumberNA
Catalog Number651005
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeUNKNOWN
Device Eval'ed by MfgrR
Implant FlagY
Date RemovedU
Device Sequence No1
Device Event Key317034
ManufacturerC.R. BARD, INC.
Manufacturer Address8195 INDUSTRIAL BLVD. COVINGTON GA 30014 US
Baseline Brand NameCONTIGEN BARD COLLAGEN IMPLANT
Baseline Generic NameINCONTINENCE IMPLANT
Baseline Model NoNA
Baseline Catalog No651005
Baseline IDNA
Baseline Device FamilyBARD CONTIGEN IMPLANT
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]36
Baseline PMA FlagY
Premarket ApprovalP9000
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2001-04-16

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.